市場調查報告書
商品編碼
1540957
2024-2032 年按設備技術、應用、最終用戶和地區分類的消融設備市場報告Ablation Devices Market Report by Device Technology, Application, End User, and Region 2024-2032 |
IMARC Group年全球消融器械市場規模達59億美元。危及生命的疾病的日益流行、電生理學去除異常組織的廣泛採用,以及帶有機器人導航系統的下一代消融設備的開發,是推動市場發展的一些關鍵因素。
消融裝置是在各種醫療程序中用於移除或破壞組織的醫療器械或工具,通常目的是治療或控制某些醫療狀況。這些設備的工作原理是將熱、冷或射頻等能量傳遞到目標組織,導致其被去除或改變。消融手術是微創手術,通常比傳統手術方法更受歡迎,因為它們通常可以減輕疼痛、縮短恢復時間並降低併發症的風險。
該市場正在經歷由幾個關鍵因素推動的成長,包括癌症、心房顫動和慢性靜脈功能不全(CVI)等危及生命的疾病的盛行率不斷增加。疾病發生率的上升凸顯了對有效消融手術的需求。此外,大眾對微創消融技術可用性的認知不斷增強,正在推動市場擴張。這些手術具有許多優點,包括減輕疼痛、最小化疤痕、減少不適以及加速患者康復時間。此外,透過移除異常組織來解決不規則心律和心律不整的電生理學程序的廣泛採用對市場成長做出了重大貢獻。此外,製造商還透過製造非熱、非腫脹和非硬化的靜脈內消融裝置來滿足不斷變化的醫療需求,這些裝置專為有效治療淺靜脈逆流而設計。
危及生命的疾病的盛行率不斷增加
癌症仍然是全世界死亡的主要原因之一,近年來發病率不斷上升。消融手術,特別是在腫瘤學領域,作為手術的微創替代方案而受到重視。它們被用來破壞各種器官中的癌組織,例如肝臟、腎臟和肺臟。此外,CVI 是一種腿部靜脈無法將血液充分返回心臟的疾病,導致疼痛、腫脹和皮膚變化。靜脈內消融手術現在通常用於透過封閉故障靜脈來治療 CVI。 CVI 發病率的上升通常與生活方式因素和衰老有關,這推動了對用於靜脈治療的消融設備的需求。
電生理學的廣泛採用
電生理學是心臟病學的一個分支,研究心臟的電活動。由於其在診斷和治療包括心房顫動在內的各種心律不整方面的有效性,它的採用率激增。電生理學引導的消融手術涉及精確定位和消除心臟中異常電訊號的來源。這種方法已成為許多心律不整的護理標準,為患者提供緩解症狀和提高生活品質的機會。此外,隨著醫療保健專業人員越來越認知到電生理引導消融的好處,其採用已經廣泛,導致對相關消融裝置和設備的需求不斷成長。
下一代消融設備與機器人導航系統的整合
消融設備領域的技術進步是一個重要的驅動力。下一代消融設備採用機器人導航系統,可提高精確度、準確度和手術結果。機器人輔助消融可以實現更受控和更有針對性的組織消融,降低併發症的風險並改善患者的治療效果。這些機器人系統提供治療區域的即時成像和繪圖,使醫療保健提供者能夠更有信心地導航複雜的解剖結構。因此,這些先進消融設備的採用正在增加,特別是在尋求提供最先進治療選擇的醫療機構中。提高病人安全性和手術成功率的承諾進一步刺激了對這些設備的需求。
The global ablation devices market size reached US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2032, exhibiting a growth rate (CAGR) of 10.2% during 2024-2032. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
IMARC Group provides an analysis of the key trends in each segment of the global ablation devices market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on device technology, application and end user.
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Others
Radiofrequency devices represent the most used device technology
The report has provided a detailed breakup and analysis of the market based on the device technology. This includes radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. According to the report, radiofrequency devices represented the largest segment.
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Others
Cancer treatment holds the largest market share
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. According to the report, cancer treatment represented the largest segment.
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals
Ambulatory Surgical Centers
Others
Hospitals accounts for majority of market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
Abbott Laboratories
AngioDynamics Inc.
AtriCure Inc.
Boston Scientific Corporation
CONMED Corporation
Elekta AB (publ)
Johnson & Johnson
Medtronic plc
Olympus Corporation
Smith & Nephew plc
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Abbott has made notable developments in the field of ablation devices. They have introduced the EnSite Precision(TM) cardiac mapping system, which offers high-resolution imaging and accurate mapping of the heart. This technology enables precise identification of abnormal tissue during ablation procedures, improving the success rate of the treatment.
Johnson & Johnson has been actively involved in the development of innovative ablation technologies. It has introduced the TactiCath Contact Force Ablation Catheter, which provides real-time feedback on the amount of force applied during cardiac ablation procedures. This helps in achieving better outcomes and reducing the risk of complications.
Medtronic Plc have introduced the Arctic Front Advance Cryoballoon System, which is used for the treatment of atrial fibrillation. This system offers improved efficiency and precision in cardiac ablation procedures.